• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0033677707
Medical Device Problem Codes Break (1069); Material Deformation (2976)
Health Effect - Clinical Codes Cardiac Arrest (1762); Ventricular Fibrillation (2130); Obstruction/Occlusion (2422)
Date of Event 05/22/2025
Type of Reportable Event Death
Additional Manufacturer Narrative
Good faith effort attempts were made to try and retrieve additional details regarding the reported event, but further information was unable to be obtained.
 
Event or Problem Description
It was reported that the patient died.The patient was admitted for an elective coronary angiogram following a positive ct coronary angiogram (ctca).The procedure was initiated via right radial artery access, and a 7f non-boston scientific radial sheath was inserted.Angiography revealed severely calcified left anterior descending (lad) artery lesions, which was also noted to be moderately tortuous.A 6f guidezilla ii guide extension catheter was engaged to assist device advancement.Rotational atherectomy was performed using a 1.50 mm rotapro device.Intravascular ultrasound (ivus) was then performed followed by multiple balloon inflations with 3.00mm x 15mm, 2.75mm x 12mm and 2.50mm x 12mm nc emerge balloon catheters.The balloon inflations were carried out in the proximal and mid-lad segments.During this process, hypotensive episodes were observed and managed with multiple aramine boluses.A 2.50 x 32 mm synergy xd drug-eluting stent was then advanced down the lad.While optimal positioning was performed, the stent shaft was sheared, noted possibly due to contact with heavily calcified plaque.A portion of the shaft, including the undeployed stent and stent balloon, became detached and lodged within the lad, resulting in vessel occlusion.The patients condition began to deteriorate, and a code blue was activated.A cardiothoracic surgeon was urgently contacted, and advanced life support (als) measures were initiated.The patient went into ventricular fibrillation (vf) and was defibrillated with 200 joules.Cardiopulmonary resuscitation (cpr) was performed, and sinus rhythm was restored after the initial shock.Preparation began to transfer the patient to cardiac surgery.The patient was intubated and then deteriorated back into vf, which required four additional defibrillation shocks, three 1 mg doses of adrenaline, and 300 mg of amiodarone, administered according to als protocol.A lucas mechanical cpr device was applied, and resuscitative efforts were continued during transfer to the cardiac surgery room for urgent coronary artery bypass grafting (cabg).An emergency sternotomy was performed, and cardiopulmonary bypass was initiated via femoral cannulation.The patient underwent cabg to right coronary artery (rca) x 2, lad, and distal posterior descending artery (pda), with left atrial appendage (laa) ligation also completed.The stent, balloon, and sheared shaft were successfully retrieved during surgery.The procedure was completed.The retrieved stent strut was also noted to be deformed.The patient was subsequently transferred to the intensive care unit (icu).However, despite all interventions, the patient passed away the following day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key22248204
Report Number2124215-2025-37627
Device Sequence Number13102409
Product Code NIQ
UDI-Device Identifier08714729980193
UDI-Public(01)08714729980193(17)260307(10)33677707
Combination Product (Y/N)Y
Initial Reporter CountryAS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Lot Number0033677707
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/23/2025
Initial Report FDA Received Date06/17/2025
Date Device Manufactured03/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient SexUnknown
-
-